The Recall Desk
ModerateFDA (Devices)·Z-1415-2014·Announced 2014-04-16

LumiQuick CK-MB Test Cards Recalled for Unapproved Distribution

LumiQuick Diagnostics is recalling CK-MB Test Cards shipped to US locations without required FDA clearance.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text explicitly states no illnesses or injuries were reported, and the hazard is regulatory (unapproved distribution) rather than a direct physical defect causing harm.

Plain-English summary

LumiQuick Diagnostics Inc. is recalling CK-MB Test Cards (serum), catalog number 75007, all lots. The recall involves products shipped to US locations that do not have approved applications for PMA, IDE, or 510(k) clearance.

The recall is being conducted because the products were distributed in states including California, Florida, New Jersey, Texas, and New York without the necessary regulatory approvals. The source text does not report any specific illnesses, injuries, or deaths associated with the use of these test cards.

Consumers and healthcare facilities should stop using the affected test cards and contact the manufacturer for further instructions.

The recalled product

Product
CK-MB Test Card (serum); LumiQuick,. Santa Clara, CA 95054

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Catalog number: 75007
  • All lots

Distribution

Distributed in 5 states:

Part of a larger recall action

This product is one of 80 recalled by LumiQuick Diagnostics Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 80 products in this recall →

Same manufacturer · LumiQuick Diagnostics Inc.

See all →